Skinvisible (SKVI) Accounts Payables (2010 - 2026)
Skinvisible's (SKVI) quarterly Accounts Payables came in at $1.4 million in Q2 2026, up 29.93% year-over-year from $1.1 million in Q2 2025, and up 3.68% quarter-over-quarter from $1.4 million in Q1 2026.
Analysis
Skinvisible (SKVI) Accounts Payables (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Accounts Payables across 17 years of filings, most recently posting $1.4 million for Q2 2026.
- In Q2 2026, Accounts Payables rose 29.93% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (up 29.93% YoY), while the FY2025 annual figure was $1.3 million, up 45.95% from the prior year.
- Accounts Payables came in at $1.4 million for Q2 2026 at Skinvisible, up from $1.4 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.4 million in Q2 2026 to a low of $126057.0 in Q1 2023.
- Average Accounts Payables over 5 years is $878660.9, with a median of $991985.5 recorded in 2022.
- Year-over-year, Accounts Payables plunged 86.66% in 2023 and surged 322.74% in 2024.
- Over 5 years, Accounts Payables stood at $1.2 million in 2022, then tumbled by 63.5% to $438668.0 in 2023, then soared by 95.82% to $858993.0 in 2024, then surged by 45.95% to $1.3 million in 2025, then grew by 12.05% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $1.4 million in Q2 2026, $1.4 million in Q1 2026, and $1.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 441.56 Bn | 434.99 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 364.45 Bn | 357.31 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 267.46 Bn | 259.77 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 158.77 Bn | 147.08 Bn | 10.94 Bn | 4.58 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.31 Bn | 20.77 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 1.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 959,324.00 |
| Dec 31, 2024 | 858,993.00 |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 659,692.00 |
| Mar 31, 2024 | 532,888.00 |
| Dec 31, 2023 | 438,668.00 |
| Sep 30, 2023 | 328,320.00 |
| Jun 30, 2023 | 228,468.00 |
| Mar 31, 2023 | 126,057.00 |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 944,629.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 1.03 Mn |